Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils.
Maruta
Fukuto
F
Sugiyama
Atsushi
A
Ishizone
Satoshi
S
Miyagawa
Shinichi
S
Ota
Hiroyoshi
H
Katsuyama
Tsutomu
T
D000658:Amoxicillin / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D015197:Carcinogenicity Tests; D049109:Cell Proliferation / Q000187:drug effects; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D004847:Epithelial Cells / Q000187:drug effects; D005753:Gastric Mucosa / Q000166:cytology / Q000187:drug effects / Q000473:pathology*; D005849:Gerbillinae; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology*; D016480:Helicobacter pylori / Q000187:drug effects*; D065347:Hypromellose Derivatives; D008297:Male; D008747:Methylcellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D009853:Omeprazole / Q000627:therapeutic use; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D009883:Ophthalmic Solutions; D065347:Hypromellose Derivatives; D000658:Amoxicillin; D008747:Methylcellulose; D009853:Omeprazole